<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39349051</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 spike aggravates lupus nephritis and lung fibrosis in systemic lupus erythematosus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001104</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2023-001104</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">COVID-19 induces the development of autoimmune diseases, including SLE, which are characterised by inflammation, autoantibodies and thrombosis. However, the effects of COVID-19 on SLE remain unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We investigated the effects of COVID-19 on SLE development and progression in three animal models. Plasmids encoding SARS-CoV-2 spike protein and ACE2 receptor were injected into R848-induced BALB/C lupus mice, R848-induced IL-1 receptor antagonist knockout (KO) lupus mice and MRL/lpr mice. Serum levels of albumin and autoantibodies, lymphocyte phenotypes and tissue histology were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In R848-induced BALB/C lupus mice, the SARS-CoV-2 spike protein increased autoantibody and albumin levels compared with vehicle and mock treatments. These mice also exhibited splenomegaly, which was further exacerbated by the spike protein. Flow cytometric analysis revealed elevated T helper 1 cell counts, and histological analysis indicated increased levels of the fibrosis marker protein α-smooth muscle actin. In KO mice, the spike protein induced splenomegaly, severe kidney damage and pronounced lung fibrosis. In the MRL/lpr group, spike protein increased the serum levels of autoantibodies, albumin and the thrombosis marker chemokine (C-X-C motif) ligand 4.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">COVID-19 accelerated the development and progression of lupus by inducing autoantibody production, fibrosis and thrombosis.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yeon Su</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Graduate School of The Catholic University of Korea, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Jin Seok</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhun</LastName><ForeName>JooYeon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Graduate School of The Catholic University of Korea, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jeong Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>A Ram</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Graduate School of The Catholic University of Korea, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kun Hee</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Graduate School of The Catholic University of Korea, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Haeyoun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sung-Hwan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Mi-La</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0001-5715-3989</Identifier><AffiliationInfo><Affiliation>Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea iammila@catholic.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Graduate School of The Catholic University of Korea, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="Y">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="Y">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="N">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013163" MajorTopicYN="N">Splenomegaly</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">pulmonary fibrosis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39349051</ArticleId><ArticleId IdType="pmc">PMC11448135</ArticleId><ArticleId IdType="doi">10.1136/lupus-2023-001104</ArticleId><ArticleId IdType="pii">11/2/e001104</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tanaka Y. State-of-the-art treatment of systemic lupus erythematosus. Int J Rheum Dis. 2020;23:465–71. doi: 10.1111/1756-185X.13817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13817</ArticleId><ArticleId IdType="pmc">PMC7187183</ArticleId><ArticleId IdType="pubmed">32134201</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy EH. Clinical significance of Janus Kinase inhibitor selectivity. Rheumatol (Oxford) 2019;58:1122. doi: 10.1093/rheumatology/kez002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez002</ArticleId><ArticleId IdType="pmc">PMC6532441</ArticleId><ArticleId IdType="pubmed">30698756</ArticleId></ArticleIdList></Reference><Reference><Citation>Thim-Uam A, Prabakaran T, Tansakul M, et al. Erratum: STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation. i Sci. 2020;23:101706. doi: 10.1016/j.isci.2020.101706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101706</ArticleId><ArticleId IdType="pmc">PMC7644739</ArticleId><ArticleId IdType="pubmed">33196029</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Liu L, Zhang L, et al. Case Report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus. Front Pediatr. 2022;10:1004053. doi: 10.3389/fped.2022.1004053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.1004053</ArticleId><ArticleId IdType="pmc">PMC9932912</ArticleId><ArticleId IdType="pubmed">36819195</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Homood IA. Thrombosis in systemic lupus erythematosus: a review article. ISRN Rheumatol. 2012;2012:428269. doi: 10.5402/2012/428269.</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/428269</ArticleId><ArticleId IdType="pmc">PMC3413961</ArticleId><ArticleId IdType="pubmed">22900201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello N, Meyers KJ, Workman J, et al. Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus. Rheumatol Ther. 2023;10:7–34. doi: 10.1007/s40744-022-00513-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-022-00513-1</ArticleId><ArticleId IdType="pmc">PMC9931974</ArticleId><ArticleId IdType="pubmed">36471199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis. Thromb J. 2015;13:16. doi: 10.1186/s12959-015-0043-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-015-0043-3</ArticleId><ArticleId IdType="pmc">PMC4407320</ArticleId><ArticleId IdType="pubmed">25908929</ArticleId></ArticleIdList></Reference><Reference><Citation>England BR, Roul P, Yang Y, et al. Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals. Arthritis Rheumatol . 2021;73:2179–88. doi: 10.1002/art.41800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41800</ArticleId><ArticleId IdType="pmc">PMC8239709</ArticleId><ArticleId IdType="pubmed">33955209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–43. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002. doi: 10.1111/jth.14888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14888</ArticleId><ArticleId IdType="pmc">PMC7497052</ArticleId><ArticleId IdType="pubmed">32369666</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384:2092–101. doi: 10.1056/NEJMoa2104840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384:2124–30. doi: 10.1056/NEJMoa2104882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WJ, Tang XX. Virus infection induced pulmonary fibrosis. J Transl Med. 2021;19:496. doi: 10.1186/s12967-021-03159-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03159-9</ArticleId><ArticleId IdType="pmc">PMC8649310</ArticleId><ArticleId IdType="pubmed">34876129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng G, Chen P, Wei Y, et al. Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis. Chest. 2020;157:1175–87. doi: 10.1016/j.chest.2019.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.10.032</ArticleId><ArticleId IdType="pmc">PMC7214095</ArticleId><ArticleId IdType="pubmed">31730835</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol. 2021;12:742941. doi: 10.3389/fimmu.2021.742941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742941</ArticleId><ArticleId IdType="pmc">PMC8515020</ArticleId><ArticleId IdType="pubmed">34659238</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355–62. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon HY, Uh ST. Post-Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention. Tuberc Respir Dis (Seoul) 2022;85:320–31. doi: 10.4046/trd.2022.0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.4046/trd.2022.0053</ArticleId><ArticleId IdType="pmc">PMC9537661</ArticleId><ArticleId IdType="pubmed">35722706</ArticleId></ArticleIdList></Reference><Reference><Citation>Spihlman AP, Gadi N, Wu SC, et al. COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics. Front Immunol. 2020;11:589474. doi: 10.3389/fimmu.2020.589474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589474</ArticleId><ArticleId IdType="pmc">PMC7661632</ArticleId><ArticleId IdType="pubmed">33193418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruera S, Lei X, Zhao H, et al. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus. Lupus Sci Med. 2023;10:e000750. doi: 10.1136/lupus-2022-000750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2022-000750</ArticleId><ArticleId IdType="pmc">PMC9929928</ArticleId><ArticleId IdType="pubmed">36787921</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res. 2021;232:13–36. doi: 10.1016/j.trsl.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7749645</ArticleId><ArticleId IdType="pubmed">33352298</ArticleId></ArticleIdList></Reference><Reference><Citation>Assar S, Pournazari M, Soufivand P, et al. Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review. Egypt Rheumatol . 2022;44:145–9. doi: 10.1016/j.ejr.2021.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2021.08.013</ArticleId><ArticleId IdType="pmc">PMC8511647</ArticleId><ArticleId IdType="pubmed">38620966</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi K, Kuwahara H, Fujimoto Y, et al. Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome. Cureus. 2023;15:e35290. doi: 10.7759/cureus.35290.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35290</ArticleId><ArticleId IdType="pmc">PMC10039762</ArticleId><ArticleId IdType="pubmed">36974237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Chan JF-W, Yuen K-Y. Animal models in SARS-CoV-2 research. Nat Methods. 2022;19:392–4. doi: 10.1038/s41592-022-01447-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-022-01447-w</ArticleId><ArticleId IdType="pubmed">35396468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467–70. doi: 10.1136/jcp.41.4.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.41.4.467</ArticleId><ArticleId IdType="pmc">PMC1141479</ArticleId><ArticleId IdType="pubmed">3366935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 2003;170:3915–25. doi: 10.4049/jimmunol.170.7.3915.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.7.3915</ArticleId><ArticleId IdType="pubmed">12646661</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J-S, Kim N-R, Lim M-A, et al. Deficiency of IL-1 receptor antagonist suppresses IL-10-producing B cells in autoimmune arthritis in an IL-17/Th17-dependent manner. Immunol Lett. 2018;199:44–52. doi: 10.1016/j.imlet.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2018.05.003</ArticleId><ArticleId IdType="pubmed">29803636</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33:155–62. doi: 10.1097/BOR.0000000000000776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford) 2021;60:SI37–50. doi: 10.1093/rheumatology/keab250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab250</ArticleId><ArticleId IdType="pmc">PMC7989171</ArticleId><ArticleId IdType="pubmed">33725121</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16:413–4. doi: 10.1038/s41584-020-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11:329–41. doi: 10.1038/nrneph.2015.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.33</ArticleId><ArticleId IdType="pubmed">25825084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisitkun P, Deane JA, Difilippantonio MJ, et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312:1669–72. doi: 10.1126/science.1124978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1124978</ArticleId><ArticleId IdType="pubmed">16709748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Muzio M, Ghezzi P, et al. Regulation of inhibitory pathways of the interleukin-1 system. Ann N Y Acad Sci. 1998;840:338–51. doi: 10.1111/j.1749-6632.1998.tb09573.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1998.tb09573.x</ArticleId><ArticleId IdType="pubmed">9629261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Ren Y, He X. IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis. Front Immunol. 2021;12:676082. doi: 10.3389/fimmu.2021.676082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676082</ArticleId><ArticleId IdType="pmc">PMC8093624</ArticleId><ArticleId IdType="pubmed">33959133</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12:825–35. doi: 10.2215/CJN.05780616.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazzi B, Fine D, Geetha D, et al. New-onset lupus nephritis associated with COVID-19 infection. Lupus (Los Angel) 2022;31:1007–11. doi: 10.1177/09612033221098571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221098571</ArticleId><ArticleId IdType="pmc">PMC9066225</ArticleId><ArticleId IdType="pubmed">35485455</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf AS, Cheong XK, Rozita M, et al. A case of lupus nephritis flare-up in severe COVID-19 infection. Med J Malaysia. 2021;76:757–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">34508391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahallawi WH, Khabour OF, Zhang Q, et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8–13. doi: 10.1016/j.cyto.2018.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC7129230</ArticleId><ArticleId IdType="pubmed">29414327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20:345–6. doi: 10.1038/s41577-020-0328-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0328-z</ArticleId><ArticleId IdType="pmc">PMC7194244</ArticleId><ArticleId IdType="pubmed">32358580</ArticleId></ArticleIdList></Reference><Reference><Citation>White CS. Interstitial Pulmonary Fibrosis in Systemic Lupus Erythematosus: Are There Variants of the Variant Fibrotic Patterns? Radiol Cardiothorac Imaging . 2021;3:e210183. doi: 10.1148/ryct.2021210183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2021210183</ArticleId><ArticleId IdType="pmc">PMC8415144</ArticleId><ArticleId IdType="pubmed">34498011</ArticleId></ArticleIdList></Reference><Reference><Citation>Dema B, Charles N. Autoantibodies in SLE: Specificities, Isotypes and Receptors. Antibodies (Basel) 2016;5:2. doi: 10.3390/antib5010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib5010002</ArticleId><ArticleId IdType="pmc">PMC6698872</ArticleId><ArticleId IdType="pubmed">31557984</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020;16:565–79. doi: 10.1038/s41584-020-0480-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0480-7</ArticleId><ArticleId IdType="pmc">PMC8456518</ArticleId><ArticleId IdType="pubmed">32884126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12:5417. doi: 10.1038/s41467-021-25509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J, Cecchinato V, Cavalli A, et al. Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat Immunol. 2023;24:604–11. doi: 10.1038/s41590-023-01445-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01445-w</ArticleId><ArticleId IdType="pmc">PMC10063443</ArticleId><ArticleId IdType="pubmed">36879067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska MA, Rauova L, Poncz M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res. 2010;125:292–6. doi: 10.1016/j.thromres.2009.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2009.11.023</ArticleId><ArticleId IdType="pubmed">20004006</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Toma F, Uzun G, et al. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia. Blood. 2022;139:3430–8. doi: 10.1182/blood.2021013839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021013839</ArticleId><ArticleId IdType="pmc">PMC8949646</ArticleId><ArticleId IdType="pubmed">35679071</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76:412–20. doi: 10.1136/thoraxjnl-2020-216243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578–89. doi: 10.1002/ajh.25982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25982</ArticleId><ArticleId IdType="pmc">PMC7674272</ArticleId><ArticleId IdType="pubmed">32857878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SM, Lee J, Jang SG, et al. Type I Interferon Increases Inflammasomes Associated Pyroptosis in the Salivary Glands of Patients with Primary Sjögren’s Syndrome. Immune Netw. 2020;20:e39. doi: 10.4110/in.2020.20.e39.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2020.20.e39</ArticleId><ArticleId IdType="pmc">PMC7609163</ArticleId><ArticleId IdType="pubmed">33163247</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CS, Kim SH, Lee CK. Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines. Immune Netw. 2020;20:e47. doi: 10.4110/in.2020.20.e47.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2020.20.e47</ArticleId><ArticleId IdType="pmc">PMC7779869</ArticleId><ArticleId IdType="pubmed">33425432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AR, Woo JS, Lee S-Y, et al. SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis. Cell Commun Signal. 2023;21:44. doi: 10.1186/s12964-023-01044-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-023-01044-0</ArticleId><ArticleId IdType="pmc">PMC9978284</ArticleId><ArticleId IdType="pubmed">36864432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>